Skip to main content
. 2021 Aug 26;2021(8):CD006190. doi: 10.1002/14651858.CD006190.pub3

Comparison 1. Low‐dose colchicine versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1.1 Proportion with 50% or greater decrease in pain score from baseline 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
1.1.1 24 hours 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
1.1.2 32 hours 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
1.2 Total adverse events 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected
1.3 Gastrointestinal adverse events (diarrhoea, vomiting or nausea) 1   Risk Ratio (M‐H, Fixed, 95% CI) Totals not selected
1.4 Serious adverse events 1   Risk Ratio (M‐H, Random, 95% CI) Subtotals only
1.5 Withdrawals due to adverse events 1   Risk Ratio (M‐H, Random, 95% CI) Totals not selected